GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $282,000 | -95.3% | 6,000 | -95.7% | 0.03% | -95.6% |
| Q3 2019 | $5,948,000 | +7.8% | 139,373 | +1.1% | 0.77% | +7.6% |
| Q2 2019 | $5,518,000 | -1.9% | 137,882 | +2.4% | 0.72% | -3.8% |
| Q1 2019 | $5,626,000 | +8.3% | 134,641 | -0.9% | 0.74% | -2.2% |
| Q4 2018 | $5,193,000 | -9.7% | 135,918 | -5.0% | 0.76% | -1.0% |
| Q3 2018 | $5,750,000 | -3.1% | 143,133 | -2.8% | 0.77% | -7.5% |
| Q2 2018 | $5,934,000 | +3.0% | 147,205 | -0.2% | 0.83% | +0.5% |
| Q1 2018 | $5,760,000 | +8.1% | 147,435 | -1.9% | 0.83% | +10.9% |
| Q4 2017 | $5,330,000 | -18.9% | 150,275 | -7.2% | 0.74% | -23.4% |
| Q3 2017 | $6,572,000 | -9.3% | 161,857 | -3.6% | 0.97% | -11.1% |
| Q2 2017 | $7,242,000 | +1.3% | 167,937 | -1.0% | 1.10% | +0.2% |
| Q1 2017 | $7,149,000 | +11.9% | 169,562 | +2.2% | 1.09% | +5.6% |
| Q4 2016 | $6,388,000 | -8.9% | 165,882 | +2.0% | 1.04% | -12.8% |
| Q3 2016 | $7,014,000 | +3.0% | 162,633 | +3.5% | 1.19% | +0.3% |
| Q2 2016 | $6,811,000 | +17.5% | 157,146 | +9.9% | 1.18% | +13.4% |
| Q1 2016 | $5,799,000 | +21.2% | 143,021 | +20.6% | 1.04% | +23.0% |
| Q4 2015 | $4,784,000 | +7.1% | 118,558 | +2.0% | 0.85% | +5.2% |
| Q3 2015 | $4,467,000 | -2.7% | 116,185 | +5.4% | 0.81% | +7.0% |
| Q2 2015 | $4,591,000 | -7.0% | 110,229 | +3.1% | 0.75% | -5.5% |
| Q1 2015 | $4,934,000 | +10.3% | 106,909 | +2.1% | 0.80% | +8.4% |
| Q4 2014 | $4,474,000 | -3.0% | 104,683 | +4.4% | 0.74% | -5.4% |
| Q3 2014 | $4,611,000 | -9.7% | 100,306 | +5.0% | 0.78% | -6.8% |
| Q2 2014 | $5,109,000 | +4.7% | 95,530 | +4.6% | 0.84% | +1.6% |
| Q1 2014 | $4,879,000 | +4.4% | 91,313 | +4.3% | 0.82% | +2.9% |
| Q4 2013 | $4,675,000 | +3.5% | 87,564 | -2.7% | 0.80% | -9.3% |
| Q3 2013 | $4,515,000 | -19.4% | 89,990 | -19.8% | 0.88% | -23.1% |
| Q2 2013 | $5,603,000 | – | 112,138 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |